IP Library Granted Patent US 11,583,853
Granted Patent B2
US 11,583,853 · App. 16/543,028 · Granted Feb 21, 2023

Kits and devices for detecting analytes

Inventors: Greg Yantz (Somerville, MA); Don Straus (Cambridge, MA); Gordon Siek (Somerville, MA); Damon Dehart (Bedford, MA)
Assignee: FIRST LIGHT DIAGNOSTICS, INC.
B01L3/502715A61B5/157A61B5/150022A61B5/15113A61B5/15186A61B5/150213A61B5/150221A61B5/150274A61B5/150305A61B5/150343A61B5/150351A61B5/150412A61B5/150503A61B5/150786B01L3/5029B01L3/5082B01L3/502761G01N21/03G01N21/253G01N21/6452G01N21/6458G01N33/54373A61B5/117A61B5/151B01L7/00B01L9/52B01L2200/025B01L2200/026B01L2200/027B01L2200/0605B01L2200/10B01L2300/022B01L2300/042B01L2300/043B01L2300/046B01L2300/048B01L2300/0654B01L2300/0681B01L2300/0864B01L2400/043B01L2400/0406B01L2400/0409B01L2400/0415B01L2400/0457B01L2400/0472B01L2400/0481B01L2400/0677B01L2400/0683G01N21/6428G01N2021/0325G01N2021/0346
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,583,853
App. No.
16/543,028
Granted
Feb 21, 2023
Kind
B2
Abstract

The invention provides devices that improve tests for detecting specific cellular, viral, and molecular targets in clinical, industrial, or environmental samples. The invention permits efficient detection of individual microscopic targets at low magnification for highly sensitive testing. The invention does not require washing steps and thus allows sensitive and specific detection while simplifying manual operation and lowering costs and complexity in automated operation. In short, the invention provides devices that can deliver rapid, accurate, and quantitative, easy-to-use, and cost-effective tests.

Claims (18)

1. A testing cartridge comprising:

at least one reservoir operable to receive a sample and fluidically connected to an imaging well comprising a detection area;

a growth well positioned between the at least one reservoir and the imaging well and containing growth media and at least one antibiotic;

signaling moieties and selection moieties stored in the at least one reservoir; and

a dye cushion reagent in the imaging well, the dye cushion reagent having a density agent and a dye that inhibits transmission of light.

2. The testing cartridge of claim 1 , wherein the density agent has a density greater than water.

3. The testing cartridge of claim 2 , wherein the density agent is selected from the group consisting of sucrose, diatrizoate, iodixanol, NaCl, CsCl, Percoll, metrizamide, and albumin.

4. The testing cartridge of claim 1 , wherein the signaling moieties and selection moieties specifically bind a target,

wherein the detection area is transparent at wavelengths corresponding to a signal signature of the signaling moieties, and

wherein the device comprising the imaging well comprises features for alignment or registration of the imaging well with an imagining analyzer.

5. The testing cartridge of claim 1 , wherein the longest linear dimension of the detection area is 2 cm, and wherein the depth of the imaging well is less than 2 cm.

6. The testing cartridge of claim 1 , wherein the selection moieties are magnetic particles.

7. The testing cartridge of claim 1 , wherein the signaling moieties are fluorescent particles.

8. The testing cartridge of claim 1 , wherein the signaling moieties are fluorescent or fluorogenic stains.

9. The testing cartridge of claim 1 , wherein the signaling moieties or selection moieties are stored in one of the one or more reservoirs in dry form.

10. The testing cartridge of claim 1 , wherein the imaging well has a depth of ≥2 mm and the detection area has a shortest linear dimension of ≥1 mm.

11. The testing cartridge of claim 1 , wherein the at least one reservoir is disposed above the imaging well.

12. The testing cartridge of claim 1 , comprising a second growth well positioned between the at least one reservoir and a second imaging well and containing growth media without antibiotic.

Assignments (4)
CONFIRMATORY LICENSE Recorded Sep 8, 2023
From: FIRST LIGHT DIAGNOSTICS, INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064851/0987 →
CHANGE OF NAME Recorded Jan 30, 2020
From: FIRST LIGHT BIOSCIENCES, INC.
To: FIRST LIGHT DIAGNOSTICS, INC.
Reel/Frame 051758/0358 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2020
From: YANTZ, GREG; STRAUS, DON; SIEK, GORDON; DEHART, DAMON
To: STRAUS HOLDINGS INC.
Reel/Frame 051542/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2020
From: STRAUS HOLDINGS INC.
To: FIRST LIGHT BIOSCIENCES, INC.
Reel/Frame 051542/0599 →
Continuity (3)
Continuation 13120504
Provisional Application 61099830 · Sep 24, 2008
Related Publication 20190366338A1 · Dec 5, 2019